美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾伯維公司

198.47

+5.132.65%

盤後：199.030.5605+0.28%19:59 EDT

成交量：642.52萬

成交額：12.67億

市值：3,510.89億

市盈率：84.82

高：198.98

開：195.17

低：194.63

收：193.34

資料載入中...

總覽公司新聞公告

更新 1-美國針對諾和諾德的 Ozempic 和 Wegovy 進行醫療保險價格談判

眾多仿製藥衝擊之下艾伯維(ABBV.US)“昔日藥王”修美樂份額仍遙遙領先

更新版 1-艾伯維首席執行官表示，艾伯維計劃 "減少 "對精神科藥物的資金投入

艾伯維首席執行官表示將 "減少 "對精神科藥物的資金投入

艾伯維下跌1.24%，報174.55美元/股

首款狂犬病雙抗在國內報上市、先聲再明三抗新藥授權艾伯維、默沙東 PD-1 單抗在國內獲批新適應症

医药经济报

先聲再明就多發性骨髓瘤候選藥物與艾伯維達成開發許可選擇協議

10.55億美元！先聲再明與艾伯維就多發性骨髓瘤三抗候選創新藥開發達成合作

先聲藥業與AbbVie達成SIM0500海外許可協議，最高可獲10.55億美元付款

中國先聲藥業授予艾伯維血癌候選藥物許可權

先聲藥業與AbbVie就SIM0500訂立海外許可選擇權協議

【先聲藥業(02096.HK)附屬與AbbVie就SIM0500訂立海外許可選擇權協議】先聲藥業(02096.HK)公佈，於2025年1月13日，該集團附屬公司山東先聲生物製藥有限公司(山東先聲)與AbbVie Inc.(股票代碼：ABBV)的附屬公司訂立許可選擇權協議。根據該協議條款，AbbVie將擁有研究性新候選藥物SIM0500的許可選擇性權益。SIM0500正在中美兩國針對復發或難治性多發性骨髓瘤(MM)患者進行臨牀I期研究。

2025年買什麼？從電動車到美妝，策略師看好四大潛力股

BUZZ-貝倫貝格稱，肥胖症藥物和併購是 2025 年製藥業的主要驅動力

艾伯維下調2024財年盈測低於市場預期

艾伯維下調 2024 年利潤預期

虎氣生財 | 策略師：2025年值得買入這四隻股票；CES 2025即將開幕：AI可能又要唱主角；交易員上週五爭相買入Nvidia

醫藥行業：艾伯維JAK抑制劑UPADACITINIB新適應症在華申報上市

太平洋证券股份...

估值窪地之下，2025年這些生物科技股股價有望突破

老虎资讯综合

艾伯維上漲1.21%，報177.7美元/股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ABBV/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABBV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABBV\",,,,,undefined,":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯維公司","latestPrice":198.47,"timestamp":1746216000000,"preClose":193.34,"halted":0,"volume":6425160,"hourTrading":{"tag":"盘后","latestPrice":199.0305,"preClose":198.47,"latestTime":"19:59 EDT","volume":227266,"amount":45105891.0077,"timestamp":1746230370674},"delay":0,"floatShares":1765081572,"shares":1768978278,"eps":2.339923,"marketStatus":"休市中","change":5.13,"latestTime":"05-02 16:00:00 EDT","open":195.17,"high":198.98,"low":194.63,"amount":1267255831.086,"amplitude":0.022499,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.339923,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":193.34,"dividendRate":0.032146,"preHourTrading":{"tag":"盘前","latestPrice":194.51,"preClose":193.34,"latestTime":"09:29 EDT","volume":190221,"amount":36788646.2895,"timestamp":1746192599076},"postHourTrading":{"tag":"盘后","latestPrice":199.0305,"preClose":198.47,"latestTime":"19:59 EDT","volume":227266,"amount":45105891.0077,"timestamp":1746230370674},"volumeRatio":0.7688190831757297,"optionData":{"bulkOrders":[{"symbol":"ABBV","call":true,"expireDate":1750392000000,"strike":"210.0","timestamp":1746199799315,"price":2.44,"volume":3001,"amount":732244,"type":"-"}]},"impliedVol":0.2934,"impliedVolPercentile":0.736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABBV\",,,,,undefined,":{"symbol":"ABBV","floatShares":1765081572,"roa":"8.49%","roe":"62.29%","lyrEps":2.395703,"volumeRatio":0.7688190831757297,"shares":1768978278,"dividePrice":6.38,"high":198.98,"amplitude":0.022499,"preClose":193.34,"low":194.63,"week52Low":153.58,"pbRate":"105.59","psRate":"6.12","week52High":218.66,"institutionHeld":0,"latestPrice":198.47,"eps":2.339923,"divideRate":0.032146,"volume":6425160,"delay":0,"ttmEps":2.339923,"open":195.17,"prevYearClose":177.7,"prevWeekClose":186.06,"prevMonthClose":195.1,"prevQuarterClose":209.52,"fiveDayClose":186.06,"twentyDayClose":201.64,"sixtyDayClose":191.75},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABBV\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2504504151","title":"更新 1-美國針對諾和諾德的 Ozempic 和 Wegovy 進行醫療保險價格談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2504504151","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504504151?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 21:05","pubTimestamp":1737119138,"startTime":"0","endTime":"0","summary":"     路透华盛顿1月17日 - 美国政府周五表示，诺和诺德公司的  糖尿病治疗药物Ozempic和减肥治疗药物Wegovy是2027年医疗保险价格谈判的15种目标药物之一。其他上榜药物包括辉瑞  的抗癌药Ibrance和Xtandi、葛兰素史克  的哮喘和慢性阻塞性肺病 治疗药物Trelegy Ellipta、梯瓦  的亨廷顿氏病治疗药物Austedo和艾伯维  的肠易激综合征治疗药物Linzess。所选药品的生产商将在 2 月 28 日前决定是否参加谈判。这 15 种新药是第二批进入该程序的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","BK4568","LU1983299246.USD","LU1244550494.USD","BK4559","LU0114720955.EUR","LU1894683264.USD","LU2133065610.SGD","LU0203345920.USD","LU2089984988.USD","LU1883839398.USD","LU0985320562.USD","LU2468319806.SGD","LU2237443382.USD","SGXZ57979304.SGD","BK4534","LU0795875086.SGD","LU1267930490.SGD","IE00B2B36J28.USD","PFE","LU0965509010.AUD","LU0289739699.SGD","LU0943347566.SGD","LU0965508806.USD","ABBV","BK4585","LU1894683348.USD","SG9999015978.USD","LU1066053197.SGD","LU0225284248.USD","IE00BLSP4239.USD","LU1093756325.SGD","LU0128525929.USD","IE0009355771.USD","SG9999002224.SGD","LU0912757837.SGD","LU1291159041.SGD","BK4599","BK4566","LU1057294990.SGD","LU0708994859.HKD","LU1496350171.SGD","LU0882574055.USD","LU1037948541.HKD","NVO","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","LU1989771016.USD"],"gpt_icon":1},{"id":"2504906466","title":"眾多仿製藥衝擊之下 艾伯維(ABBV.US)“昔日藥王”修美樂份額仍遙遙領先","url":"https://stock-news.laohu8.com/highlight/detail?id=2504906466","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504906466?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 11:52","pubTimestamp":1737085927,"startTime":"0","endTime":"0","summary":"尽管截至2024年2月，艾伯维修美乐仍以96%的市场份额保持其主导地位，但随着CVS Health等大型药品与药房福利管理机构将该品牌药从主要药品处方集中彻底移除，修美乐的市场领导地位在2024年5月受到了威胁，市场份额降至77%，但仍然占据阿达木单抗市场的绝对主导地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1239202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"众多仿制药冲击之下 艾伯维(ABBV.US)“昔日药王”修美乐份额仍遥遥领先","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU0198837287.USD","ABBV","LU0738911758.USD","LU1934455863.HKD","SG9999011175.SGD","LU1496350502.SGD","SG9999015978.USD","LU1585245621.USD","IE00B42XCP33.USD","IE00BVYPNV92.GBP","LU2237443465.HKD","LU1037948897.HKD","LU0965509283.SGD","LU1983299246.USD","LU1989772923.USD","LU0689472784.USD","LU1093756325.SGD","LU2237443622.USD","SG9999015986.USD","LU0234572021.USD","LU2237443382.USD","LU0211328371.USD","LU0029864427.USD","LU1934455277.USD","LU2089984988.USD","LU0965509010.AUD","LU1244550221.USD","IE00B3PB1722.GBP","IE00BSNM7G36.USD","LU0170899867.USD","LU1267930490.SGD","LU1291159041.SGD","LU1839511570.USD","IE0009355771.USD","BK4585","LU2237443978.SGD","LU1061106388.HKD","BK4139","LU1732799900.SGD","LU2089284900.SGD","LU1551013425.SGD","LU0122379950.USD","LU2347655156.SGD","LU0456855351.SGD","LU0949170772.SGD","LU0310800379.SGD","LU2237443895.HKD","SG9999003800.SGD","LU0158827948.USD"],"gpt_icon":0},{"id":"2503295627","title":"更新版 1-艾伯維首席執行官表示，艾伯維計劃 \"減少 \"對精神科藥物的資金投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2503295627","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503295627?lang=zh_tw&edition=fundamental","pubTime":"2025-01-16 01:26","pubTimestamp":1736962002,"startTime":"0","endTime":"0","summary":"     路透1月15日 - 艾伯维  首席执行官罗伯特-迈克尔周三在一次行业会议上表示，公司将 \"减少 \"对精神疾病实验药物的投入。这番话是在其试验性精神分裂症药物在两项中期研究中失败几个月后说的。\"迈克尔补充说：\"我们可以减少资金投入，尤其是在心理方面，但这并不会改变我们承担经过深思熟虑的风险的意愿。艾伯维表示，它将记录一笔与该药物有关的约35亿美元的费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU0256863811.USD","BK4581","LU1989771016.USD","LU0114720955.EUR","LU0820561818.USD","LU2133065610.SGD","LU1934455277.USD","LU1267930490.SGD","LU0170899867.USD","LU1003077747.HKD","LU1839511570.USD","LU1057294990.SGD","LU0198837287.USD","IE00B42XCP33.USD","LU2237443382.USD","LU2237443549.SGD","LU0234570918.USD","LU1430594728.SGD","SG9999001440.SGD","LU2087621335.USD","LU0456855351.SGD","LU1093756325.SGD","ABBV","LU2023251221.USD","BK4566","LU0545039389.USD","IE00BGHQF631.EUR","LU2089284900.SGD","LU1061106388.HKD","BK4533","LU1244550221.USD","LU2237443622.USD","IE00BVYPNV92.GBP","LU0256863902.USD","IE00BJJMRZ35.SGD","LU0738911758.USD","LU1934455194.USD","LU2237443465.HKD","LU1244550494.USD","LU1934455863.HKD","LU0985320562.USD","LU0029864427.USD","LU1585245621.USD","LU0234572021.USD","SG9999015986.USD","LU0122379950.USD","LU2237443895.HKD","LU1983299246.USD","LU0965509010.AUD"],"gpt_icon":0},{"id":"2503462227","title":"艾伯維首席執行官表示將 \"減少 \"對精神科藥物的資金投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2503462227","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503462227?lang=zh_tw&edition=fundamental","pubTime":"2025-01-16 01:08","pubTimestamp":1736960915,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透1月15日 - 艾伯维公司  首席执行官罗伯特-迈克尔（Robert Michael）周三在一次行业会议上表示，将减少对精神疾病实验药物的资金投入。 这番话是在实验性精神分裂症药物在两项中期研究中失败几个月后说的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU0965509283.SGD","LU0912757837.SGD","LU2023251221.USD","LU0545039389.USD","IE00BJT1NW94.SGD","LU2237443622.USD","LU0985320562.USD","LU1989772923.USD","LU1023059063.AUD","LU2237443978.SGD","LU1934455277.USD","LU2089984988.USD","LU1244550494.USD","SG9999015986.USD","IE0002141913.USD","IE00BVYPNW00.USD","LU0965508806.USD","LU1496350502.SGD","LU0553294199.USD","LU0128525929.USD","LU0820561818.USD","LU1244550577.SGD","LU0122379950.USD","LU1496350171.SGD","LU0211327993.USD","LU1057294990.SGD","LU1718418525.SGD","LU1732800096.USD","BK4534","LU2237443549.SGD","LU2237443895.HKD","LU1989771016.USD","LU1037948897.HKD","BK4585","LU0234572021.USD","IE0009355771.USD","BK4533","ABBV","LU1983299246.USD","LU1839511570.USD","LU1934455194.USD","LU1585245621.USD","LU1267930490.SGD","LU1003077747.HKD","LU1061106388.HKD","LU0256863902.USD","LU0708994859.HKD","LU0661504455.SGD","LU0949170772.SGD"],"gpt_icon":0},{"id":"2503508756","title":"艾伯維下跌1.24%，報174.55美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2503508756","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503508756?lang=zh_tw&edition=fundamental","pubTime":"2025-01-15 00:04","pubTimestamp":1736870649,"startTime":"0","endTime":"0","summary":"1月15日，艾伯维(ABBV)盘中下跌1.24%，截至00:04，报174.55美元/股，成交1.74亿美元。财务数据显示，截至2024年09月30日，艾伯维收入总额412.32亿美元，同比增长3.04%；归母净利润43.0亿美元，同比增长6.41%。大事提醒：1月31日，艾伯维将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115001008960390db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115001008960390db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965508806.USD","LU1037948541.HKD","LU0738911758.USD","LU1934455277.USD","IE00BFTCPJ56.SGD","IE00B42XCP33.USD","LU1023059063.AUD","LU1003077747.HKD","LU1934455863.HKD","BK4559","BK4534","LU0965509010.AUD","LU1267930490.SGD","LU0128525929.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1037948897.HKD","LU1244550221.USD","LU1989772923.USD","IE00BVYPNW00.USD","LU1291159041.SGD","LU2089284900.SGD","LU0114720955.EUR","LU1093756325.SGD","LU0965509101.SGD","LU1585245621.USD","IE00BSNM7G36.USD","LU2089283258.USD","LU0203347892.USD","SG9999015945.SGD","LU0553294199.USD","LU1061106388.HKD","ABBV","BK4566","LU2112291526.USD","LU2087621335.USD","LU1093756168.USD","LU2237443978.SGD","LU1551013425.SGD","LU0882574055.USD","LU0256863902.USD","LU1934455194.USD","LU1989771016.USD","SG9999001440.SGD","LU1057294990.SGD","LU2023251221.USD","LU2237443549.SGD","LU1267930573.SGD","IE00B4R5TH58.HKD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2503833540","title":"首款狂犬病雙抗在國內報上市、先聲再明三抗新藥授權艾伯維、默沙東 PD-1 單抗在國內獲批新適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=2503833540","media":"医药经济报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503833540?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 18:17","pubTimestamp":1736849828,"startTime":"0","endTime":"0","summary":"智翔金泰狂犬病双抗在国内报上市今日，CDE 官网显示，智翔金泰 1 类新药“斯乐韦米单抗”在国内报上市。斯乐韦米单抗主要开发用于疑似狂犬病病毒 III 级暴露后的被动免疫。值得注意的是，该药也是狂犬病领域首款且目前唯一的双抗药物。根据该协议条款，先声再明将从艾伯维收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。至此，帕博利珠单抗在中国获批的适应症已经达到 19 个。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114183403abaa6dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114183403abaa6dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2106854487.HKD","SG9999013999.USD","LU1571399168.USD","LU0158827948.USD","IE00B4R5TH58.HKD","LU0912757837.SGD","IE00BN8TJ469.HKD","LU1699723380.USD","LU0545039389.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","MRK","LU0861579265.USD","LU2237443978.SGD","LU1169589451.USD","SG9999015952.SGD","IE00BLSP4239.USD","LU2089984988.USD","LU0820561909.HKD","LU0320765646.SGD","LU1244550494.USD","LU0965509010.AUD","SG9999001176.SGD","LU1496350502.SGD","LU1244550577.SGD","LU2461242641.AUD","LU0738911758.USD","LU1551013342.USD","SGXZ57979304.SGD","LU0310800379.SGD","LU1496350171.SGD","SG9999015945.SGD","BK4534","LU1244550221.USD","LU0456855351.SGD","SG9999015358.SGD","SG9999011175.SGD","LU0234572021.USD","LU1941712264.USD","PD","ABBV","LU1974910355.USD","IE00BVYPNV92.GBP","LU1941712348.USD","LU0203345920.USD","SG9999014567.USD","LU0203347892.USD","LU0965509101.SGD","IE0004445239.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2503651596","title":"先聲再明就多發性骨髓瘤候選藥物與艾伯維達成開發許可選擇協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2503651596","media":"红星新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503651596?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 11:37","pubTimestamp":1736825820,"startTime":"0","endTime":"0","summary":"红星资本局1月14日消息，1月13日，先声药业集团 旗下抗肿瘤创新药公司先声再明宣布，已与全球制药公司艾伯维就先声再明正在中美两国进行临床I期研究的多发性骨髓瘤候选药物SIM0500达成开发许可选择协议。资料配图 图据视觉中国根据该协议条款，先声再明将从艾伯维收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。多发性骨髓瘤是第二大血液瘤，可以影响多个器官和组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501141138039602e5f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501141138039602e5f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU0234570918.USD","IE00BDGV0183.EUR","LU0256863811.USD","LU1718418525.SGD","LU1989771016.USD","LU2237443382.USD","BK4139","LU0545039389.USD","LU0965509010.AUD","IE00BJJMRZ35.SGD","LU0965509101.SGD","LU0553294199.USD","LU1037948541.HKD","LU1291159041.SGD","LU0861579265.USD","LU1496350171.SGD","LU1003077747.HKD","LU2089283258.USD","LU0198837287.USD","LU0949170772.SGD","LU1732800096.USD","LU0882574055.USD","BK4550","LU0661504455.SGD","LU1244550577.SGD","SG9999015978.USD","IE00B42XCP33.USD","ABBV","SG9999015945.SGD","LU1496350502.SGD","LU0965509283.SGD","BK4559","LU2237443895.HKD","IE00B2B36J28.USD","BK4588","LU2237443549.SGD","LU2023251221.USD","LU1732799900.SGD","LU2089984988.USD","LU1023059063.AUD","LU0170899867.USD","LU0965508806.USD","LU2347655156.SGD","LU2087621335.USD","LU0795875169.SGD","LU0310800379.SGD","LU0234572021.USD","LU0128525929.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2503564609","title":"10.55億美元！先聲再明與艾伯維就多發性骨髓瘤三抗候選創新藥開發達成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2503564609","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503564609?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 09:38","pubTimestamp":1736818688,"startTime":"0","endTime":"0","summary":"2025年1月13日，先声药业集团旗下抗肿瘤创新药公司先声再明与全球生物制药公司艾伯维宣布，双方已就先声再明的在研候选药物SIM0500达成许可选择协议。SIM0500目前正在中美两国开展针对复发或难治性多发性骨髓瘤的临床I期研究。根据该协议条款，先声再明将从艾伯维收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。多发性骨髓瘤是第二大血液瘤，可以影响多个器官和组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140941199602c47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140941199602c47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BDGV0183.EUR","LU0029864427.USD","LU0310800379.SGD","LU1989771016.USD","BK4559","LU0211328371.USD","LU2133065610.SGD","LU1003077747.HKD","LU1093756325.SGD","LU0965509010.AUD","LU0861579265.USD","LU1061106388.HKD","LU0158827948.USD","LU0689472784.USD","LU0882574055.USD","LU1057294990.SGD","LU0795875086.SGD","LU1093756168.USD","LU1244550577.SGD","LU0985320562.USD","IE00BJT1NW94.SGD","LU0198837287.USD","LU0943347566.SGD","LU1551013425.SGD","LU0114720955.EUR","IE00BVYPNW00.USD","LU1551013342.USD","LU1934455863.HKD","LU1718418525.SGD","LU0912757837.SGD","SG9999015952.SGD","LU0234570918.USD","LU2237443382.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1934455194.USD","LU1983299246.USD","LU1732800096.USD","LU1585245621.USD","LU1244550494.USD","LU1839511570.USD","ABBV","BK4534","LU2237443895.HKD","IE00BVYPNV92.GBP","LU0965509101.SGD","LU0965509283.SGD","LU0661504455.SGD","IE00B3PB1722.GBP","LU0203347892.USD"],"gpt_icon":0},{"id":"2503564677","title":"先聲藥業與AbbVie達成SIM0500海外許可協議，最高可獲10.55億美元付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2503564677","media":"财中社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503564677?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 09:35","pubTimestamp":1736818503,"startTime":"0","endTime":"0","summary":"财中社1月14日电先声药业 发布公告，与AbbVie签订了关于研究性新候选药物SIM0500的海外许可选择权协议。根据协议，AbbVie将获得SIM0500的许可选择性权益，该药物目前正在中美两国针对复发或难治性多发性骨髓瘤患者进行临床I期研究。公司将从AbbVie收取首付款，以及最高10.55亿美元的选择性权益付款和里程碑付款。文章来源：财中社先声药业与AbbVie达成SIM0500海外许可协议，最高可获10.55亿美元付款","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114094641aba9d54f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114094641aba9d54f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1934455863.HKD","ABBV","LU1983299246.USD","LU0158827948.USD","LU1732800096.USD","LU1093756168.USD","IE00BSNM7G36.USD","LU1003077747.HKD","LU0203347892.USD","LU0029864427.USD","IE00B3PB1722.GBP","IE00BVYPNW00.USD","LU0114720955.EUR","LU1551013342.USD","BK4559","LU1244550494.USD","LU0689472784.USD","LU0795875086.SGD","LU0211328371.USD","LU0912757837.SGD","LU1093756325.SGD","LU0985320562.USD","LU0310800379.SGD","LU0234570918.USD","LU0965509010.AUD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1057294990.SGD","LU1244550577.SGD","LU1718418525.SGD","LU1551013425.SGD","LU0861579265.USD","LU1061106388.HKD","IE00BDGV0183.EUR","LU1585245621.USD","IE00BJT1NW94.SGD","IE00BVYPNV92.GBP","LU1839511570.USD","SG9999015952.SGD","LU0198837287.USD","LU2237443895.HKD","LU2133065610.SGD","LU0943347566.SGD","LU0965509101.SGD","LU2237443382.USD","LU0661504455.SGD","LU0965509283.SGD","LU1934455194.USD","LU1989771016.USD","BK4534"],"gpt_icon":0},{"id":"2503005613","title":"中國先聲藥業授予艾伯維血癌候選藥物許可權","url":"https://stock-news.laohu8.com/highlight/detail?id=2503005613","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503005613?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 22:13","pubTimestamp":1736777596,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透1月13日 - 先声药业  周一称，该公司已授予美国制药商艾伯维  在中国以外地区许可其血癌新药候选药物的选择权。根据协议，艾伯维将向先声药业支付高达10.6亿美元的费用，以及在中国境外销售的特许权使用费。艾伯维将从中国境内的销售中收取特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550494.USD","BK4585","LU0417517546.SGD","SG9999001440.SGD","SG9999015986.USD","LU0912757837.SGD","LU1934455194.USD","BK4581","IE00B3PB1722.GBP","IE00BSNM7G36.USD","LU1585245621.USD","SG9999011175.SGD","LU1989772923.USD","LU1983299246.USD","IE00B2B36J28.USD","LU0170899867.USD","BK4566","LU1093756168.USD","LU1551013425.SGD","LU0256863811.USD","LU2087621335.USD","LU0820561818.USD","ABBV","LU0965509101.SGD","BK4533","02096","IE00BVYPNW00.USD","LU1267930573.SGD","LU0553294199.USD","SG9999003800.SGD","LU2089284900.SGD","LU0158827948.USD","IE0004445239.USD","LU0795875169.SGD","LU1496350171.SGD","LU0689472784.USD","BK4588","IE00B42XCP33.USD","LU1934455277.USD","LU2468319806.SGD","LU1267930490.SGD","LU1551013342.USD","LU0545039389.USD","LU1244550221.USD","IE00BDGV0183.EUR","LU2089283258.USD","LU0943347566.SGD","LU0128525929.USD","IE00BJT1NW94.SGD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2503300920","title":"先聲藥業與AbbVie就SIM0500訂立海外許可選擇權協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2503300920","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503300920?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 21:59","pubTimestamp":1736776784,"startTime":"0","endTime":"0","summary":"根据该协议条款，AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤患者进行临床I期研究。根据该协议条款，集团将从Abb Vie收取首付款，以及最高10.55亿美金的选择性权益付款和里程碑付款。Abb Vie有权就大中华地区净销售额收取分级特许权使用费。SIM0500通过多种抗肿瘤机制，表现出了针对MM细胞的强大T细胞毒性效应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132159449864ce2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132159449864ce2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965509283.SGD","LU2347655156.SGD","LU1003077747.HKD","LU1551013342.USD","BK4139","LU1989772840.SGD","ABBV","LU2089984988.USD","LU2087621335.USD","LU1989772923.USD","LU0861579265.USD","LU0882574055.USD","LU1934455277.USD","LU2237443549.SGD","IE0004445239.USD","02096","LU0198837287.USD","LU0943347566.SGD","IE00B2B36J28.USD","LU0122379950.USD","LU1093756325.SGD","BK4534","SG9999015952.SGD","LU2237443382.USD","IE00BVYPNW00.USD","LU1267930490.SGD","SG9999003800.SGD","LU0203347892.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","IE00BVYPNV92.GBP","LU2023251221.USD","IE00BFTCPJ56.SGD","SG9999015945.SGD","SG9999015986.USD","LU1291159041.SGD","LU1267930573.SGD","IE00BGHQF631.EUR","IE0009355771.USD","LU2237443895.HKD","SG9999015978.USD","LU0795875086.SGD","LU0738911758.USD","LU1023059063.AUD","LU1934455863.HKD","LU0128525929.USD","LU0203345920.USD","IE00B3PB1722.GBP","LU0114720955.EUR","LU0949170772.SGD","BK4559"],"gpt_icon":0},{"id":"2503307339","title":"【先聲藥業(02096.HK)附屬與AbbVie就SIM0500訂立海外許可選擇權協議】先聲藥業(02096.HK)公佈，於2025年1月13日，該集團附屬公司山東先聲生物製藥有限公司(山東先聲)與AbbVie Inc.(股票代碼：ABBV)的附屬公司訂立許可選擇權協議。根據該協議條款，AbbVie將擁有研究性新候選藥物SIM0500的許可選擇性權益。SIM0500正在中美兩國針對復發或難治性多發性骨髓瘤(MM)患者進行臨牀I期研究。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503307339","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503307339?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 21:57","pubTimestamp":1736776666,"startTime":"0","endTime":"0","summary":"先声药业(02096.HK)公布，于2025年1月13日，该集团附属公司山东先声生物制药有限公司(山东先声)与AbbVie Inc.(股票代码：ABBV)的附属公司订立许可选择权协议。根据该协议条款，AbbVie将拥有研究性新候选药物SIM0500的许可选择性权益。SIM0500正在中美两国针对复发或难治性多发性骨髓瘤(MM)患者进行临床I期研究。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/13215747401967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE0004445239.USD","LU0820561909.HKD","LU1057294990.SGD","LU1551013425.SGD","LU0158827948.USD","BK4550","LU1037948897.HKD","LU1718418525.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU2089984988.USD","SG9999015978.USD","LU0661504455.SGD","LU0203347892.USD","LU0965509010.AUD","IE00BJT1NW94.SGD","LU2133065610.SGD","LU0198837287.USD","IE0002141913.USD","LU1291159041.SGD","LU0114720955.EUR","IE00BGHQF631.EUR","LU2089283258.USD","LU0128525929.USD","LU0965508806.USD","LU0256863902.USD","SG9999003800.SGD","02096","LU1430594728.SGD","LU0234570918.USD","LU0310799852.SGD","BK1583","LU0912757837.SGD","LU0689472784.USD","LU1585245621.USD","LU2237443549.SGD","LU2023251221.USD","LU1037948541.HKD","LU0456855351.SGD","LU1989772840.SGD","LU0256863811.USD","BK4581","LU0211328371.USD","IE00B3PB1722.GBP","LU1496350171.SGD","LU1989772923.USD","LU2237443465.HKD","SG9999015952.SGD","LU0985320562.USD","ABBV"],"gpt_icon":0},{"id":"2502705063","title":"2025年買什麼？從電動車到美妝，策略師看好四大潛力股","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705063","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502705063?lang=zh_tw&edition=fundamental","pubTime":"2025-01-09 13:21","pubTimestamp":1736400069,"startTime":"0","endTime":"0","summary":"“2025年的股市可能会波动，但专注于个股选择的投资者将迎来重大机会，”Marketgauge.com的首席市场策略师Michele Schneider表示。从美妆品牌到电动车公司，以下是Schneider预计今年将跑赢市场的四只股票。Ulta Beauty的股价在过去12个月下跌了约9.4%。经历了艰难的2024年，Rivian在过去12个月下跌了近35%。根据FactSet的数据，其平均目标价为14.83美元，意味着有11.9%的上涨潜力。Schneider表示，Chewy因其客户服务而闻名，目前正在扩大服务范围，包括处方药和宠物保险。Chewy在过去12个月上涨了超过60%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/01/09132147288704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4099","LU1430594728.SGD","LU0820561818.USD","BK4122","IE0009355771.USD","LU1585245621.USD","BK4200","LU1037948897.HKD","LU2133065610.SGD","LU2023251221.USD","LU2087621335.USD","LU0198837287.USD","LU0738911758.USD","IE00B3PB1722.GBP","LU2237443978.SGD","CHWY","IE00BSNM7G36.USD","LU1732800096.USD","LU0234570918.USD","LU0965509101.SGD","IE00B42XCP33.USD","LU0545039389.USD","IE00B2B36J28.USD","BK4555","IE00BFTCPJ56.SGD","LU1267930573.SGD","LU0114720955.EUR","LU0949170772.SGD","LU0203347892.USD","ULTA","SG9999003800.SGD","BK4566","BK4547","LU0820561909.HKD","ABBV","LU1839511570.USD","LU0256863902.USD","BK4548","RIVN","IE0002141913.USD","LU0553294199.USD","LU1496350171.SGD","LU0985320562.USD","LU1718418525.SGD","BK4559","SG9999015978.USD","LU0211328371.USD","SG9999001440.SGD","LU1934455277.USD","IE0004445239.USD"],"gpt_icon":1},{"id":"2501205516","title":"BUZZ-貝倫貝格稱，肥胖症藥物和併購是 2025 年製藥業的主要驅動力","url":"https://stock-news.laohu8.com/highlight/detail?id=2501205516","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501205516?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 20:55","pubTimestamp":1736254525,"startTime":"0","endTime":"0","summary":"    1月7日 - ** 贝伦贝格在其 2025 年制药业展望中指出，肥胖症药物将成为管道新闻的主要内容，而中国的特定股票问题应开始缓解** 贝伦贝格认为，肥胖症药物生产商的销售额将增长 26%，其中新兴的口服治疗药物将受到密切关注，而未涉足减肥治疗药物的生产商的销售额增长将放缓。** 它还预计今年将出现并购热潮，约有 570 亿美元的未分配现金可供其覆盖的公司用于并购和业务发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU1974910355.USD","LU1868836914.USD","LU1032466523.USD","SG9999018857.SGD","LU0708995401.HKD","LU2491050154.USD","LU1066053197.SGD","PFE","IE00BJT1NW94.SGD","SGXZ31699556.SGD","BMY","IE00BLSP4452.SGD","BK4534","LU1093756325.SGD","BK4007","IE00BDGV0183.EUR","LU2089984988.USD","GB00BDT5M118.USD","MRK","LU0203202063.USD","LU2602419157.SGD","LU2125154935.USD","LU1585245621.USD","LU2360106947.USD","LU1983299246.USD","LU2468319806.SGD","LU0965508806.USD","LU0061475181.USD","LU0006306889.USD","LU1670711123.USD","LU0122379950.USD","SG9999014914.USD","LU1989772923.USD","LU2491049909.HKD","LU2361045086.USD","SG9999011175.SGD","BK4532","IE000M9KFDE8.USD","LLY","BK4559","IE00B2B36J28.USD","LU0985481810.HKD","SG9999015952.SGD","LU2242646821.SGD","ABBV","LU1732799900.SGD","SG9999015358.SGD","LU0882574055.USD","BK4585"],"gpt_icon":1},{"id":"2501213387","title":"艾伯維下調2024財年盈測 低於市場預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2501213387","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501213387?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 09:00","pubTimestamp":1736211623,"startTime":"0","endTime":"0","summary":"格隆汇1月7日｜美国生物技术公司艾伯维下调2024财年调整后的每股盈利预测，由原先的10.9-10.94美元降至10.02-10.06美元，不及市场平均预期的10.94美元，因里程碑付款以及研究与开发成本相关的费用达到16亿美元。艾伯维预计第四季调整后每股盈利介乎2.06-2.1美元，去年同期为2.79美元。公司计划于1月31日公布第四季业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010709003595fae90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010709003595fae90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","LU0965509101.SGD","IE0004445239.USD","LU0820561909.HKD","LU1496350502.SGD","LU1551013425.SGD","LU1093756325.SGD","LU1037948897.HKD","LU1244550221.USD","LU1718418525.SGD","IE00B4R5TH58.HKD","LU2347655156.SGD","LU2237443978.SGD","LU0661504455.SGD","BK4585","SG9999011175.SGD","IE00B42XCP33.USD","LU0198837287.USD","IE0002141913.USD","IE00BVYPNV92.GBP","LU1291159041.SGD","LU0114720955.EUR","LU1934455194.USD","LU2237443382.USD","LU2089283258.USD","LU0170899867.USD","LU0256863902.USD","LU1061106388.HKD","LU1023059063.AUD","BK4559","LU1430594728.SGD","LU2112291526.USD","LU2089284900.SGD","LU0795875086.SGD","LU0689472784.USD","LU0545039389.USD","LU1839511570.USD","LU0553294199.USD","BK4139","LU2237443895.HKD","BK4581","LU1989772923.USD","LU2237443465.HKD","SG9999015952.SGD","LU0029864427.USD","LU2087621335.USD","ABBV","LU1934455863.HKD","LU1732799900.SGD","LU1989771016.USD"],"gpt_icon":0},{"id":"2501267987","title":"艾伯維下調 2024 年利潤預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2501267987","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501267987?lang=zh_tw&edition=fundamental","pubTime":"2025-01-07 05:11","pubTimestamp":1736197879,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透1月6日 - 艾伯维  周一下调了2024年调整后利润预期，因为该制药公司预计将产生16亿美元的收购相关费用。该公司目前预计调整后的利润在每股10.02美元至10.06美元之间，而之前的预测为每股10.90美元至10.94美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0965509101.SGD","LU1244550494.USD","SG9999001440.SGD","LU0310800379.SGD","LU2089283258.USD","IE00BFTCPJ56.SGD","SG9999003800.SGD","IE0009355771.USD","LU1934455194.USD","LU1732800096.USD","LU0738911758.USD","LU0985320562.USD","LU0661504455.SGD","LU1718418525.SGD","LU0882574055.USD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","ABBV","LU1732799900.SGD","LU1093756168.USD","LU0965509283.SGD","LU1934455277.USD","BK4533","LU1934455863.HKD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2237443895.HKD","LU1003077747.HKD","LU1989772923.USD","LU1585245621.USD","LU2347655156.SGD","IE00B2B36J28.USD","LU0820561909.HKD","LU0256863902.USD","LU1244550221.USD","IE00BSNM7G36.USD","SG9999015986.USD","BK4566","LU0158827948.USD","LU2237443622.USD","LU0553294199.USD","LU2237443978.SGD","BK4585","BK4581","LU1496350502.SGD","LU0912757837.SGD","LU0029864427.USD","LU0820561818.USD","IE00BVYPNW00.USD"],"gpt_icon":0},{"id":"1150679972","title":"虎氣生財 |  策略師：2025年值得買入這四隻股票；CES 2025即將開幕：AI可能又要唱主角；交易員上週五爭相買入Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=1150679972","media":"老虎資訊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150679972?lang=zh_tw&edition=fundamental","pubTime":"2025-01-06 16:59","pubTimestamp":1736153958,"startTime":"0","endTime":"0","summary":"本周值得關注的投資機會有：①策略师：2025年值得買入$Ulta美容$ 等四隻股票；②CES 2025即將開幕：AI可能又要唱主角；③交易員上周五爭相買入Nvidia。經歷了艱難的2024年後，Rivian股價在過去12個月下跌了近35%。","market":"us","thumbnail":"https://static.tigerbbs.com/80aa93e0f8208440a5c51972463e78d5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/80aa93e0f8208440a5c51972463e78d5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"虎氣生財 |  策略师：2025年值得買入這四隻股票；CES 2025即將開幕：AI可能又要唱主角；交易員上周五爭...","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ULTA","GM","RIVN","CHWY","NVDA","ABBV"],"gpt_icon":1},{"id":"2495238654","title":"醫藥行業：艾伯維JAK抑制劑UPADACITINIB新適應症在華申報上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2495238654","media":"太平洋证券股份...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495238654?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 00:00","pubTimestamp":1735574400,"startTime":"0","endTime":"0","summary":"乌帕替尼缓释片是一种JAK 抑制剂，此前已在中国获批治疗多种其它适应症，该药此前于12 月10 日被CDE 正式纳入优先审评，拟定适应症为治疗成人巨细胞动脉炎。初步结果表明，RAY1225 注射液在中国成人2 型糖尿病参与者中表现出积极的疗效和良好的安全性，试验结果理想，达到预期目的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123115240998561861&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123115240998561861&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","BK4533","LU1267930573.SGD","LU1061106388.HKD","LU2089284900.SGD","LU0861579265.USD","LU0256863902.USD","LU2237443978.SGD","LU0738911758.USD","IE0002141913.USD","LU0122379950.USD","CDE","BK4581","LU1585245621.USD","LU0795875169.SGD","LU0234570918.USD","LU0456855351.SGD","LU1291159041.SGD","IE0009355771.USD","LU0545039389.USD","LU1551013425.SGD","LU1732799900.SGD","LU2237443382.USD","IE00BVYPNW00.USD","IE00BJT1NW94.SGD","LU0689472784.USD","LU1430594728.SGD","LU1839511570.USD","LU1037948541.HKD","LU1244550577.SGD","IE00BVYPNV92.GBP","ABBV","LU0203347892.USD","BK4559","LU2347655156.SGD","LU2089283258.USD","LU0965509101.SGD","LU1267930490.SGD","BK4588","LU0211327993.USD","LU1093756325.SGD","LU1934455277.USD","LU0965509010.AUD","LU0820561909.HKD","IE00BGHQF631.EUR","LU0949170772.SGD","LU0965508806.USD","LU0943347566.SGD","SG9999015978.USD","LU1551013342.USD"],"gpt_icon":0},{"id":"1131960883","title":"估值窪地之下，2025年這些生物科技股股價有望突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1131960883","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131960883?lang=zh_tw&edition=fundamental","pubTime":"2024-12-30 11:23","pubTimestamp":1735529035,"startTime":"0","endTime":"0","summary":"经过数年不佳表现后，2025年生物科技股的趋势可能开始好转，但仍需谨慎挑选一些最具创新力的公司进行投资。“专利悬崖今年开始显现，但将在2025和2026年加剧，”他说。“总之，2025年下半年可能将Insmed转型为一家拥有多种商业化产品并在两个大型适应症中启动关键研究的公司。”摩根士丹利预计，2025年底Rocket的RP-A501基因疗法在二期试验中将取得关键数据，为其股价带来催化剂。","market":"us","thumbnail":"https://community-static.tradeup.com/news/2b99d2790d61544d0e8cfc36cd09b3ab","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/2b99d2790d61544d0e8cfc36cd09b3ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"估值洼地之下，2025年这些生物科技股股价有望突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","XBI","JNJ","ABBV","RHHBY","RCKT","JAZZ","MRK","BIIB"],"gpt_icon":1},{"id":"2493971846","title":"艾伯維上漲1.21%，報177.7美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493971846","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493971846?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 04:35","pubTimestamp":1734986115,"startTime":"0","endTime":"0","summary":"12月24日，艾伯维(ABBV)盘中上涨1.21%，截至04:35，报177.7美元/股，成交4.32亿美元。财务数据显示，截至2024年09月30日，艾伯维收入总额412.32亿美元，同比增长3.04%；归母净利润43.0亿美元，同比增长6.41%。大事提醒：2025年2月7日，艾伯维将披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/24043546729784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2023251221.USD","LU0795875086.SGD","BK4566","LU0211328371.USD","IE00B42XCP33.USD","LU1244550494.USD","LU1267930573.SGD","SG9999015952.SGD","LU0861579265.USD","LU0256863902.USD","LU2237443978.SGD","LU1732800096.USD","LU0158827948.USD","IE00B2B36J28.USD","BK4581","LU2237443895.HKD","LU0965509283.SGD","LU0456855351.SGD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU0545039389.USD","LU1732799900.SGD","IE00BVYPNW00.USD","LU1496350502.SGD","LU1037948897.HKD","BK4550","LU0310800379.SGD","LU0203345920.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU0882574055.USD","LU1430594728.SGD","LU1839511570.USD","LU2468319806.SGD","IE00B3PB1722.GBP","LU1037948541.HKD","ABBV","LU1989772840.SGD","LU1989772923.USD","LU2087621335.USD","BK4588","LU0211327993.USD","LU0965509010.AUD","IE00BJJMRZ35.SGD","IE00BGHQF631.EUR","LU0949170772.SGD","LU2133065610.SGD","SG9999015978.USD","SG9999001440.SGD","BK4585"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":158,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABBV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-25","symbol":"ABBV","fiscalQuarterEnding":"2025/03","expectedEps":2.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1745553600000,"reportTimeType":"pre","actualEps":2.46},{"date":"2025-04-15","symbol":"ABBV","amount":1.64,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-15","defaultRemindTime":1744723800000,"name":"艾伯维公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-04-15","currency":"USD","dateTimestamp":1744689600000,"payDate":"2025-05-15"},{"market":"US","date":"2025-01-31","symbol":"ABBV","fiscalQuarterEnding":"2024/12","expectedEps":2.13,"name":null,"time":"盤前","type":"earning","dateTimestamp":1738299600000,"reportTimeType":"pre","actualEps":2.16},{"date":"2025-01-15","symbol":"ABBV","amount":1.64,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-15","defaultRemindTime":1736951400000,"name":"艾伯维公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-14","payableDate":"2025-01-15","currency":"USD","dateTimestamp":1736917200000,"payDate":"2025-02-14"},{"date":"2024-10-30","symbol":"ABBV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":2.95,"defaultRemindTime":1730275200000,"name":null,"time":"盤前","dateTimestamp":1730260800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABBV\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-13","recordDate":"2015-07-15","paymentDate":"2015-08-14","value":0.51,"currency":"USD"},{"executeDate":"2015-10-13","recordDate":"2015-10-15","paymentDate":"2015-11-16","value":0.51,"currency":"USD"},{"executeDate":"2016-01-13","recordDate":"2016-01-15","paymentDate":"2016-02-16","value":0.57,"currency":"USD"},{"executeDate":"2016-04-13","recordDate":"2016-04-15","paymentDate":"2016-05-16","value":0.57,"currency":"USD"},{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-08-15","value":0.57,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABBV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.3929,"hold":0.3214,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3929,"analysts":28,"updateTime":1745640000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABBV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABBV","date":"2025-05-02","current":81.529025,"percent":0.973171,"low":14.329118,"twenty":21.580616,"median":30.452813,"eighty":50.539236,"high":89.406682,"avg":36.638188,"sd":17.71232,"marketCap":342014260268},"quantilePoints":[{"date":"2020-05-08","current":17.539859,"twenty":20.945665,"median":25.002198,"eighty":35.971396,"marketCap":147966252371},{"date":"2020-05-15","current":18.949984,"twenty":20.915669,"median":24.960061,"eighty":35.971396,"marketCap":159862062322},{"date":"2020-05-22","current":19.240365,"twenty":20.875607,"median":24.92254,"eighty":35.971396,"marketCap":162311718001},{"date":"2020-05-29","current":19.359442,"twenty":20.847553,"median":24.878726,"eighty":35.971396,"marketCap":163316253064},{"date":"2020-06-05","current":19.605953,"twenty":20.775202,"median":24.837593,"eighty":35.971396,"marketCap":165395816877},{"date":"2020-06-12","current":19.315572,"twenty":20.733606,"median":24.800604,"eighty":35.971396,"marketCap":162946161198},{"date":"2020-06-19","current":20.203428,"twenty":20.654787,"median":24.775189,"eighty":35.971396,"marketCap":170436115612},{"date":"2020-06-26","current":20.082261,"twenty":20.59993,"median":24.728312,"eighty":35.971396,"marketCap":169413957127},{"date":"2020-07-02","current":20.656757,"twenty":20.591745,"median":24.665358,"eighty":35.971396,"marketCap":174260398219},{"date":"2020-07-10","current":20.228497,"twenty":20.552719,"median":24.589678,"eighty":35.971396,"marketCap":170647596678},{"date":"2020-07-17","current":21.064126,"twenty":20.544707,"median":24.552451,"eighty":35.971396,"marketCap":177696965538},{"date":"2020-07-24","current":20.286991,"twenty":20.488542,"median":24.477697,"eighty":35.971396,"marketCap":171141052498},{"date":"2020-07-31","current":24.042533,"twenty":20.471609,"median":24.448767,"eighty":35.971396,"marketCap":167263899625},{"date":"2020-08-07","current":23.571698,"twenty":20.471609,"median":24.400797,"eighty":35.971396,"marketCap":163988305218},{"date":"2020-08-14","current":24.117105,"twenty":20.471609,"median":24.360108,"eighty":35.971396,"marketCap":167782696697},{"date":"2020-08-21","current":24.063832,"twenty":20.471609,"median":24.316683,"eighty":35.971396,"marketCap":167412081715},{"date":"2020-08-28","current":23.888795,"twenty":20.471609,"median":24.278909,"eighty":35.971396,"marketCap":166194346775},{"date":"2020-09-04","current":23.305337,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":162135230310},{"date":"2020-09-11","current":22.754857,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":158305542166},{"date":"2020-09-18","current":22.858865,"twenty":20.471609,"median":24.270663,"eighty":35.971396,"marketCap":159029123797},{"date":"2020-09-25","current":21.874597,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":152181570802},{"date":"2020-10-02","current":21.846692,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":151987439145},{"date":"2020-10-09","current":22.247503,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":154775875674},{"date":"2020-10-16","current":21.884744,"twenty":20.471609,"median":24.256547,"eighty":35.971396,"marketCap":152252164132},{"date":"2020-10-23","current":21.395147,"twenty":20.472699,"median":24.256547,"eighty":35.971396,"marketCap":148846035967},{"date":"2020-10-30","current":20.347827,"twenty":20.466853,"median":24.256547,"eighty":35.971396,"marketCap":150187309234},{"date":"2020-11-06","current":22.208949,"twenty":20.466853,"median":24.228983,"eighty":35.971396,"marketCap":163924253750},{"date":"2020-11-13","current":23.689546,"twenty":20.466853,"median":24.164263,"eighty":35.971396,"marketCap":174852537333},{"date":"2020-11-20","current":24.120091,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":178030390395},{"date":"2020-11-27","current":25.088817,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":185180559783},{"date":"2020-12-04","current":25.660485,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":189400042459},{"date":"2020-12-11","current":25.435645,"twenty":20.466853,"median":24.118882,"eighty":35.971396,"marketCap":187740496971},{"date":"2020-12-18","current":24.983573,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":184403751257},{"date":"2020-12-24","current":24.698935,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":182302837288},{"date":"2020-12-31","current":25.62939,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":189170530849},{"date":"2021-01-08","current":25.658093,"twenty":20.466853,"median":24.12305,"eighty":35.971396,"marketCap":189382387720},{"date":"2021-01-15","current":26.435466,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":195120177969},{"date":"2021-01-22","current":26.516792,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":195720439103},{"date":"2021-01-29","current":24.512365,"twenty":20.466853,"median":24.163669,"eighty":35.971396,"marketCap":180925767629},{"date":"2021-02-05","current":41.585784,"twenty":20.466853,"median":24.227431,"eighty":36.040882,"marketCap":191959979647},{"date":"2021-02-12","current":39.944995,"twenty":20.466853,"median":24.256547,"eighty":36.146771,"marketCap":184386096518},{"date":"2021-02-19","current":40.172278,"twenty":20.466853,"median":24.287457,"eighty":36.294777,"marketCap":185435236266},{"date":"2021-02-26","current":41.216658,"twenty":20.466853,"median":24.337426,"eighty":36.404226,"marketCap":190256093280},{"date":"2021-03-05","current":40.818799,"twenty":20.466178,"median":24.378392,"eighty":36.750131,"marketCap":188419576323},{"date":"2021-03-12","current":41.400285,"twenty":20.466178,"median":24.379616,"eighty":36.795798,"marketCap":191103716491},{"date":"2021-03-19","current":39.564013,"twenty":20.466178,"median":24.409847,"eighty":36.844037,"marketCap":182627484379},{"date":"2021-03-26","current":40.519116,"twenty":20.466853,"median":24.44121,"eighty":37.032995,"marketCap":187036238813},{"date":"2021-04-01","current":41.490229,"twenty":20.466853,"median":24.44121,"eighty":37.085025,"marketCap":191518896358},{"date":"2021-04-09","current":41.115547,"twenty":20.466178,"median":24.440608,"eighty":37.16205,"marketCap":189789367069},{"date":"2021-04-16","current":41.257009,"twenty":20.466178,"median":24.440608,"eighty":37.259163,"marketCap":190442352617},{"date":"2021-04-23","current":42.583687,"twenty":20.466178,"median":24.440608,"eighty":37.311305,"marketCap":196566298160},{"date":"2021-04-30","current":38.142678,"twenty":20.466178,"median":24.440608,"eighty":37.626818,"marketCap":196778077257},{"date":"2021-05-07","current":39.62788,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":204440235392},{"date":"2021-05-14","current":39.860684,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205641266580},{"date":"2021-05-21","current":39.754553,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205093737656},{"date":"2021-05-28","current":38.754869,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199936368435},{"date":"2021-06-04","current":38.467289,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":198452741672},{"date":"2021-06-11","current":39.514903,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":203857382021},{"date":"2021-06-18","current":38.72748,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199795070648},{"date":"2021-06-25","current":38.67955,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":199547799521},{"date":"2021-07-02","current":39.429313,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":203415826437},{"date":"2021-07-09","current":39.912037,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":205906199930},{"date":"2021-07-16","current":40.227006,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":207531124480},{"date":"2021-07-23","current":40.463233,"twenty":20.466178,"median":24.440608,"eighty":37.772755,"marketCap":208749817891},{"date":"2021-07-30","current":30.828704,"twenty":20.466178,"median":24.440608,"eighty":37.719322,"marketCap":205411657676},{"date":"2021-08-06","current":30.354681,"twenty":20.466178,"median":24.440608,"eighty":37.391572,"marketCap":202253239637},{"date":"2021-08-13","current":30.893082,"twenty":20.466178,"median":24.440608,"eighty":37.288928,"marketCap":205840605967},{"date":"2021-08-20","current":31.513702,"twenty":20.466178,"median":24.440608,"eighty":37.212873,"marketCap":209975796712},{"date":"2021-08-27","current":31.715271,"twenty":20.466178,"median":24.440608,"eighty":37.144732,"marketCap":211318850116},{"date":"2021-09-03","current":29.604102,"twenty":20.466178,"median":24.440608,"eighty":37.055599,"marketCap":197252132881},{"date":"2021-09-10","current":28.293905,"twenty":20.466178,"median":24.440608,"eighty":36.9642,"marketCap":188522285753},{"date":"2021-09-17","current":28.572388,"twenty":20.466178,"median":24.440608,"eighty":36.820278,"marketCap":190377820062},{"date":"2021-09-24","current":28.397341,"twenty":20.466178,"median":24.440608,"eighty":36.787789,"marketCap":189211484211},{"date":"2021-10-01","current":28.93309,"twenty":20.466178,"median":24.440608,"eighty":36.538082,"marketCap":192781178785},{"date":"2021-10-08","current":29.487404,"twenty":20.466178,"median":24.440608,"eighty":36.364331,"marketCap":196474575647},{"date":"2021-10-15","current":28.996743,"twenty":20.466178,"median":24.440608,"eighty":36.272778,"marketCap":193205300913},{"date":"2021-10-22","current":28.946351,"twenty":20.466178,"median":24.440608,"eighty":36.089393,"marketCap":192869537562},{"date":"2021-10-29","current":26.897003,"twenty":20.466178,"median":24.440608,"eighty":35.979473,"marketCap":202642018254},{"date":"2021-11-05","current":27.496713,"twenty":20.466178,"median":24.440608,"eighty":35.893834,"marketCap":207160232888},{"date":"2021-11-12","current":27.447435,"twenty":20.466178,"median":24.440608,"eighty":35.826686,"marketCap":206788977991},{"date":"2021-11-19","current":27.276138,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":205498425251},{"date":"2021-11-26","current":27.339495,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":205975752977},{"date":"2021-12-03","current":27.888584,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":210112593265},{"date":"2021-12-10","current":29.441991,"twenty":20.466178,"median":24.440608,"eighty":35.789042,"marketCap":221815961943},{"date":"2021-12-17","current":30.394685,"twenty":20.466178,"median":24.440608,"eighty":35.716411,"marketCap":228993556631},{"date":"2021-12-23","current":31.230052,"twenty":20.466178,"median":24.440608,"eighty":35.617966,"marketCap":235287211086},{"date":"2021-12-31","current":31.772102,"twenty":20.466178,"median":24.440608,"eighty":35.49234,"marketCap":239371014961},{"date":"2022-01-07","current":31.650082,"twenty":20.466853,"median":24.44121,"eighty":35.38963,"marketCap":238451717119},{"date":"2022-01-14","current":31.882389,"twenty":20.466853,"median":24.44121,"eighty":35.300366,"marketCap":240201918779},{"date":"2022-01-21","current":30.969586,"twenty":20.466853,"median":24.44121,"eighty":35.215099,"marketCap":233324863770},{"date":"2022-01-28","current":32.363429,"twenty":20.466853,"median":24.44121,"eighty":35.13817,"marketCap":243826073732},{"date":"2022-02-04","current":21.543267,"twenty":20.466853,"median":24.379004,"eighty":35.104764,"marketCap":248652387402},{"date":"2022-02-11","current":21.751577,"twenty":20.466853,"median":24.314673,"eighty":35.095534,"marketCap":251056704834},{"date":"2022-02-18","current":22.071878,"twenty":20.466853,"median":24.256547,"eighty":34.992103,"marketCap":254753613990},{"date":"2022-02-25","current":22.916258,"twenty":20.466853,"median":24.228983,"eighty":34.873074,"marketCap":264499447588},{"date":"2022-03-04","current":23.072568,"twenty":20.466853,"median":24.117673,"eighty":34.437795,"marketCap":266303576494},{"date":"2022-03-11","current":22.8427,"twenty":20.466853,"median":24.068013,"eighty":34.07367,"marketCap":263650445750},{"date":"2022-03-18","current":24.396605,"twenty":20.466853,"median":24.030352,"eighty":33.659591,"marketCap":281585609576},{"date":"2022-03-25","current":24.688507,"twenty":20.466853,"median":24.030352,"eighty":33.444136,"marketCap":284954746788},{"date":"2022-04-01","current":24.895099,"twenty":20.466853,"median":24.030352,"eighty":32.161158,"marketCap":287339231436},{"date":"2022-04-08","current":26.774321,"twenty":20.466853,"median":24.030352,"eighty":32.010235,"marketCap":309029210303},{"date":"2022-04-14","current":24.838477,"twenty":20.466853,"median":24.030352,"eighty":31.911234,"marketCap":286685706014},{"date":"2022-04-22","current":23.71829,"twenty":20.466853,"median":23.990825,"eighty":31.773041,"marketCap":273756500370},{"date":"2022-04-29","current":20.789481,"twenty":20.466853,"median":23.93685,"eighty":31.728457,"marketCap":259431929637},{"date":"2022-05-06","current":21.641753,"twenty":20.471609,"median":23.919764,"eighty":31.65145,"marketCap":270067433984},{"date":"2022-05-13","current":21.736629,"twenty":20.49488,"median":23.919764,"eighty":31.65145,"marketCap":271251397740},{"date":"2022-05-20","current":21.384029,"twenty":20.584423,"median":23.919764,"eighty":31.65145,"marketCap":266851293633},{"date":"2022-05-27","current":21.241006,"twenty":20.63248,"median":23.919764,"eighty":31.65145,"marketCap":265066512450},{"date":"2022-06-03","current":20.840259,"twenty":20.656606,"median":23.919764,"eighty":31.65145,"marketCap":260065590915},{"date":"2022-06-10","current":20.27808,"twenty":20.676938,"median":23.919764,"eighty":31.65145,"marketCap":253050163885},{"date":"2022-06-17","current":19.581375,"twenty":20.676938,"median":23.919764,"eighty":31.65145,"marketCap":244355982277},{"date":"2022-06-24","current":21.572366,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":269201550044},{"date":"2022-07-01","current":21.779111,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":271781530765},{"date":"2022-07-08","current":21.644585,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":270102776186},{"date":"2022-07-15","current":21.753622,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":271463450950},{"date":"2022-07-22","current":21.024348,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":262362834023},{"date":"2022-07-29","current":20.067893,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":253597968011},{"date":"2022-08-05","current":19.313764,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":244068040169},{"date":"2022-08-12","current":19.951773,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":252130560187},{"date":"2022-08-19","current":19.846838,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":250804487815},{"date":"2022-08-26","current":19.077309,"twenty":20.671523,"median":23.920291,"eighty":31.652818,"marketCap":241079957093},{"date":"2022-09-02","current":19.067515,"twenty":20.656456,"median":23.920291,"eighty":31.652818,"marketCap":240956190338},{"date":"2022-09-09","current":19.786675,"twenty":20.595877,"median":23.920291,"eighty":31.652818,"marketCap":250044206322},{"date":"2022-09-16","current":20.156048,"twenty":20.476993,"median":23.900397,"eighty":31.652818,"marketCap":254711981069},{"date":"2022-09-23","current":20.016134,"twenty":20.455391,"median":23.887831,"eighty":31.652818,"marketCap":252943884574},{"date":"2022-09-30","current":18.777893,"twenty":20.415192,"median":23.86089,"eighty":31.652818,"marketCap":237296230593},{"date":"2022-10-07","current":19.414503,"twenty":20.32543,"median":23.832384,"eighty":31.652818,"marketCap":245341069646},{"date":"2022-10-14","current":19.999344,"twenty":20.291044,"median":23.721085,"eighty":31.652818,"marketCap":252731712995},{"date":"2022-10-21","current":20.575791,"twenty":20.264429,"median":23.655412,"eighty":31.652818,"marketCap":260016270554},{"date":"2022-10-28","current":19.464223,"twenty":20.259089,"median":23.613004,"eighty":31.652818,"marketCap":260956835438},{"date":"2022-11-04","current":19.156983,"twenty":20.231602,"median":23.54736,"eighty":31.652818,"marketCap":256837673955},{"date":"2022-11-11","current":19.800472,"twenty":20.186853,"median":23.498486,"eighty":31.652818,"marketCap":265464930624},{"date":"2022-11-18","current":20.436049,"twenty":20.140891,"median":23.460701,"eighty":31.652818,"marketCap":273986114465},{"date":"2022-11-25","current":21.047891,"twenty":20.140891,"median":23.4195,"eighty":31.652818,"marketCap":282189079823},{"date":"2022-12-02","current":21.580616,"twenty":20.140891,"median":23.312456,"eighty":31.652818,"marketCap":289331316901},{"date":"2022-12-09","current":21.501498,"twenty":20.140891,"median":23.254346,"eighty":31.652818,"marketCap":288270588622},{"date":"2022-12-16","current":21.161293,"twenty":20.140891,"median":23.143047,"eighty":31.652818,"marketCap":283709457023},{"date":"2022-12-23","current":21.506773,"twenty":20.140891,"median":23.049581,"eighty":31.652818,"marketCap":288341303841},{"date":"2022-12-30","current":21.310298,"twenty":20.140891,"median":22.955262,"eighty":31.652818,"marketCap":285707161948},{"date":"2023-01-06","current":21.961698,"twenty":20.140891,"median":22.924243,"eighty":31.652818,"marketCap":294440491445},{"date":"2023-01-13","current":20.254079,"twenty":20.128039,"median":22.88677,"eighty":31.652818,"marketCap":271546439424},{"date":"2023-01-20","current":19.725311,"twenty":20.087275,"median":22.858865,"eighty":31.652818,"marketCap":264457238759},{"date":"2023-01-27","current":19.288846,"twenty":20.063902,"median":22.808986,"eighty":31.58391,"marketCap":258605554420},{"date":"2023-02-03","current":19.146434,"twenty":20.02201,"median":22.751914,"eighty":31.360556,"marketCap":256696243518},{"date":"2023-02-10","current":22.710901,"twenty":20.005604,"median":22.710901,"eighty":31.151136,"marketCap":268806224703},{"date":"2023-02-17","current":22.619796,"twenty":20.005604,"median":22.66283,"eighty":30.904912,"marketCap":267727909612},{"date":"2023-02-24","current":22.829087,"twenty":20.005604,"median":22.645014,"eighty":30.684887,"marketCap":270205069571},{"date":"2023-03-03","current":23.329888,"twenty":20.005604,"median":22.645014,"eighty":30.504652,"marketCap":276132559474},{"date":"2023-03-10","current":22.380607,"twenty":20.005604,"median":22.619796,"eighty":30.197139,"marketCap":264896869658},{"date":"2023-03-17","current":23.054821,"twenty":20.005604,"median":22.619796,"eighty":29.636874,"marketCap":272876863527},{"date":"2023-03-24","current":23.552694,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":278769685181},{"date":"2023-03-31","current":23.75391,"twenty":20.00721,"median":22.626275,"eighty":29.412547,"marketCap":281151276594},{"date":"2023-04-06","current":23.96705,"twenty":20.00721,"median":22.626275,"eighty":29.412547,"marketCap":283673999349},{"date":"2023-04-14","current":24.248752,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":287008227327},{"date":"2023-04-21","current":24.107156,"twenty":20.005604,"median":22.619796,"eighty":29.419908,"marketCap":285332292629},{"date":"2023-04-28","current":34.624626,"twenty":20.005604,"median":22.619796,"eighty":29.534083,"marketCap":262627787830},{"date":"2023-05-05","current":34.273426,"twenty":20.003999,"median":22.619394,"eighty":29.832035,"marketCap":259963933732},{"date":"2023-05-12","current":34.097195,"twenty":20.003999,"median":22.619394,"eighty":30.429562,"marketCap":258627224191},{"date":"2023-05-19","current":33.364497,"twenty":20.003999,"median":22.619394,"eighty":30.595519,"marketCap":253069711699},{"date":"2023-05-26","current":32.243353,"twenty":20.003999,"median":22.619394,"eighty":30.868682,"marketCap":244565835441},{"date":"2023-06-02","current":31.038473,"twenty":20.003999,"median":22.619394,"eighty":31.001499,"marketCap":235426814899},{"date":"2023-06-09","current":32.015403,"twenty":20.003999,"median":22.619394,"eighty":31.230052,"marketCap":242836831555},{"date":"2023-06-16","current":31.608349,"twenty":20.003999,"median":22.619394,"eighty":31.499834,"marketCap":239749324615},{"date":"2023-06-23","current":31.961904,"twenty":20.002393,"median":22.619796,"eighty":31.594638,"marketCap":242431044928},{"date":"2023-06-30","current":30.989626,"twenty":20.000788,"median":22.674437,"eighty":31.615327,"marketCap":235056314066},{"date":"2023-07-07","current":31.924688,"twenty":20.000788,"median":22.719209,"eighty":31.656922,"marketCap":242148758580},{"date":"2023-07-14","current":31.073363,"twenty":20.000788,"median":22.725831,"eighty":31.656922,"marketCap":235691458351},{"date":"2023-07-21","current":33.073744,"twenty":20.000788,"median":22.747044,"eighty":31.715785,"marketCap":250864349599},{"date":"2023-07-28","current":30.237711,"twenty":20.000788,"median":22.794968,"eighty":31.73628,"marketCap":262614518868},{"date":"2023-08-04","current":30.278339,"twenty":20.000788,"median":22.840032,"eighty":31.73628,"marketCap":262967376804},{"date":"2023-08-11","current":30.777049,"twenty":20.000788,"median":22.876107,"eighty":31.73628,"marketCap":267298669219},{"date":"2023-08-18","current":30.488463,"twenty":20.000788,"median":22.903399,"eighty":31.73628,"marketCap":264792302933},{"date":"2023-08-25","current":29.799516,"twenty":20.000499,"median":22.912503,"eighty":31.736322,"marketCap":258808794688},{"date":"2023-09-01","current":29.866581,"twenty":20.000499,"median":22.961834,"eighty":31.736322,"marketCap":259391260092},{"date":"2023-09-08","current":30.262879,"twenty":20.000499,"median":23.049581,"eighty":31.736322,"marketCap":262833101118},{"date":"2023-09-15","current":31.224153,"twenty":20.000499,"median":23.07874,"eighty":31.736322,"marketCap":271181771915},{"date":"2023-09-22","current":31.181475,"twenty":20.000499,"median":23.211789,"eighty":31.736322,"marketCap":270811112112},{"date":"2023-09-29","current":30.941665,"twenty":20.000499,"median":23.269501,"eighty":31.736322,"marketCap":268728357030},{"date":"2023-10-06","current":29.966164,"twenty":20.000499,"median":23.340513,"eighty":31.736322,"marketCap":260256132966},{"date":"2023-10-13","current":30.138909,"twenty":20.000499,"median":23.434713,"eighty":31.736322,"marketCap":261756422644},{"date":"2023-10-20","current":29.573931,"twenty":20.000499,"median":23.482911,"eighty":31.736322,"marketCap":256849592873},{"date":"2023-10-27","current":29.508898,"twenty":20.025934,"median":23.532342,"eighty":31.736447,"marketCap":256284777936},{"date":"2023-11-03","current":38.818021,"twenty":20.064885,"median":23.574586,"eighty":31.77145,"marketCap":252860587376},{"date":"2023-11-10","current":37.413998,"twenty":20.093125,"median":23.635568,"eighty":31.873171,"marketCap":243714785594},{"date":"2023-11-17","current":37.479047,"twenty":20.153246,"median":23.719687,"eighty":31.93114,"marketCap":244138514575},{"date":"2023-11-24","current":37.584752,"twenty":20.203428,"median":23.764425,"eighty":31.993004,"marketCap":244827074170},{"date":"2023-12-01","current":38.593011,"twenty":20.233906,"median":23.836611,"eighty":32.031772,"marketCap":251394873376},{"date":"2023-12-08","current":40.105399,"twenty":20.254383,"median":23.887831,"eighty":32.111411,"marketCap":261246572185},{"date":"2023-12-15","current":41.978268,"twenty":20.281644,"median":23.913883,"eighty":32.197857,"marketCap":273446435764},{"date":"2023-12-22","current":41.357592,"twenty":20.317955,"median":23.921773,"eighty":32.898827,"marketCap":269403355070},{"date":"2023-12-29","current":41.943033,"twenty":20.358981,"median":23.957161,"eighty":33.273317,"marketCap":273216915899},{"date":"2024-01-05","current":43.761694,"twenty":20.423435,"median":24.01817,"eighty":33.364497,"marketCap":285063671994},{"date":"2024-01-12","current":44.3905,"twenty":20.460384,"median":24.053498,"eighty":34.097195,"marketCap":289159718811},{"date":"2024-01-19","current":44.260402,"twenty":20.478089,"median":24.095977,"eighty":34.278187,"marketCap":288312260849},{"date":"2024-01-26","current":44.756401,"twenty":20.553124,"median":24.120091,"eighty":35.147938,"marketCap":291543194329},{"date":"2024-02-02","current":45.423153,"twenty":20.593863,"median":24.228723,"eighty":37.173308,"marketCap":295886416385},{"date":"2024-02-09","current":63.458418,"twenty":20.593863,"median":24.25849,"eighty":37.413998,"marketCap":308598285816},{"date":"2024-02-16","current":64.111917,"twenty":20.593863,"median":24.303452,"eighty":37.487178,"marketCap":311776253174},{"date":"2024-02-23","current":64.204023,"twenty":20.593863,"median":24.387036,"eighty":37.584752,"marketCap":312224166203},{"date":"2024-03-01","current":63.94975,"twenty":20.619083,"median":24.46262,"eighty":37.685479,"marketCap":310987634851},{"date":"2024-03-08","current":65.59163,"twenty":20.675521,"median":24.520094,"eighty":38.122626,"marketCap":318972094434},{"date":"2024-03-15","current":65.820476,"twenty":20.718499,"median":24.641098,"eighty":38.309656,"marketCap":320084972650},{"date":"2024-03-22","current":64.628797,"twenty":20.718499,"median":24.761685,"eighty":38.446792,"marketCap":314289839482},{"date":"2024-03-28","current":65.666499,"twenty":20.727926,"median":24.813227,"eighty":38.489808,"marketCap":319336183384},{"date":"2024-04-05","current":61.13338,"twenty":20.724828,"median":24.923775,"eighty":38.67955,"marketCap":297291628445},{"date":"2024-04-12","current":60.99502,"twenty":20.724828,"median":25.009872,"eighty":38.740116,"marketCap":296618782592},{"date":"2024-04-19","current":59.953677,"twenty":20.749631,"median":25.058842,"eighty":38.963687,"marketCap":291554732220},{"date":"2024-04-26","current":60.911276,"twenty":20.790512,"median":25.196454,"eighty":39.089597,"marketCap":296211533786},{"date":"2024-05-03","current":47.511721,"twenty":20.790512,"median":25.385187,"eighty":39.260827,"marketCap":284737741336},{"date":"2024-05-10","current":47.262672,"twenty":20.790512,"median":25.595836,"eighty":39.281414,"marketCap":283245192072},{"date":"2024-05-17","current":48.426559,"twenty":20.790512,"median":25.708617,"eighty":39.35331,"marketCap":290220369807},{"date":"2024-05-24","current":46.63211,"twenty":20.790512,"median":25.889623,"eighty":39.401951,"marketCap":279466235021},{"date":"2024-05-31","current":46.057533,"twenty":20.790512,"median":26.008509,"eighty":39.514903,"marketCap":276022792848},{"date":"2024-06-07","current":49.670004,"twenty":20.790512,"median":26.275101,"eighty":39.598251,"marketCap":297672331843},{"date":"2024-06-14","current":49.077747,"twenty":20.789481,"median":26.435348,"eighty":39.621033,"marketCap":294122937603},{"date":"2024-06-21","current":50.718976,"twenty":20.787742,"median":26.51701,"eighty":39.664583,"marketCap":303958821143},{"date":"2024-06-28","current":49.793759,"twenty":20.844337,"median":26.686669,"eighty":39.682345,"marketCap":298413996311},{"date":"2024-07-05","current":48.276285,"twenty":20.891877,"median":26.774321,"eighty":39.727716,"marketCap":289319777239},{"date":"2024-07-12","current":50.064841,"twenty":20.961971,"median":26.897003,"eighty":39.809021,"marketCap":300038594669},{"date":"2024-07-15","current":50.173864,"twenty":20.965963,"median":26.897106,"eighty":39.8291,"marketCap":300691965748},{"date":"2024-08-02","current":62.746353,"twenty":21.041401,"median":27.192211,"eighty":39.858924,"marketCap":335002776733},{"date":"2024-08-09","current":62.991543,"twenty":21.041401,"median":27.341842,"eighty":39.929328,"marketCap":336311849048},{"date":"2024-08-16","current":63.984057,"twenty":21.041401,"median":27.426316,"eighty":40.031862,"marketCap":341610880283},{"date":"2024-08-23","current":64.966646,"twenty":21.041401,"median":27.473717,"eighty":40.11022,"marketCap":346856921205},{"date":"2024-08-30","current":64.572949,"twenty":21.041401,"median":27.670608,"eighty":40.180948,"marketCap":344754972149},{"date":"2024-09-06","current":63.805405,"twenty":21.041401,"median":27.905087,"eighty":40.225134,"marketCap":340657054660},{"date":"2024-09-13","current":64.189177,"twenty":21.041401,"median":28.220968,"eighty":40.278795,"marketCap":342706013404},{"date":"2024-09-20","current":64.056841,"twenty":21.041401,"median":28.434472,"eighty":40.317815,"marketCap":341999475906},{"date":"2024-09-27","current":63.4878,"twenty":21.041401,"median":28.495473,"eighty":40.397704,"marketCap":338961364665},{"date":"2024-10-04","current":64.662275,"twenty":21.041401,"median":28.571062,"eighty":40.473352,"marketCap":345231884960},{"date":"2024-10-11","current":64.298353,"twenty":21.041401,"median":28.637367,"eighty":40.552864,"marketCap":343288906840},{"date":"2024-10-18","current":62.38611,"twenty":21.041401,"median":28.78987,"eighty":40.58204,"marketCap":333079439994},{"date":"2024-10-25","current":62.743415,"twenty":21.041401,"median":28.876067,"eighty":40.639084,"marketCap":334987091239},{"date":"2024-10-31","current":69.488142,"twenty":21.041401,"median":28.970221,"eighty":40.689185,"marketCap":355918264617},{"date":"2024-11-08","current":69.17792,"twenty":21.038157,"median":28.994091,"eighty":40.821941,"marketCap":354329306164},{"date":"2024-11-15","current":58.524017,"twenty":21.038157,"median":28.994091,"eighty":40.889808,"marketCap":299760012990},{"date":"2024-11-22","current":59.248537,"twenty":21.038157,"median":28.994091,"eighty":40.998263,"marketCap":303471007668},{"date":"2024-11-29","current":63.112647,"twenty":21.038157,"median":28.994091,"eighty":41.176214,"marketCap":323262979286},{"date":"2024-12-06","current":60.780381,"twenty":21.038157,"median":28.994091,"eighty":41.341004,"marketCap":311317110702},{"date":"2024-12-13","current":59.752252,"twenty":21.038157,"median":28.994091,"eighty":41.443897,"marketCap":306051032540},{"date":"2024-12-20","current":59.176085,"twenty":21.038157,"median":28.994091,"eighty":41.561559,"marketCap":303099908200},{"date":"2024-12-27","current":61.825761,"twenty":21.038157,"median":28.994091,"eighty":41.663666,"marketCap":316671545881},{"date":"2025-01-03","current":61.908563,"twenty":21.038157,"median":28.994091,"eighty":41.928939,"marketCap":317095659559},{"date":"2025-01-10","current":61.584254,"twenty":21.034912,"median":28.970221,"eighty":42.159599,"marketCap":315434547655},{"date":"2025-01-17","current":59.928207,"twenty":21.034912,"median":28.970221,"eighty":42.586745,"marketCap":306952274105},{"date":"2025-01-24","current":58.882827,"twenty":21.034912,"median":28.970221,"eighty":43.455963,"marketCap":301597838926},{"date":"2025-01-31","current":60.600976,"twenty":21.034912,"median":28.970221,"eighty":43.940578,"marketCap":310398197734},{"date":"2025-02-07","current":79.71133,"twenty":21.034912,"median":28.970221,"eighty":44.418688,"marketCap":341005068129},{"date":"2025-02-14","current":79.909606,"twenty":21.103138,"median":29.109583,"eighty":44.684847,"marketCap":341853295484},{"date":"2025-02-21","current":82.894924,"twenty":21.140099,"median":29.423589,"eighty":45.284381,"marketCap":354624484075},{"date":"2025-02-28","current":84.603332,"twenty":21.18493,"median":29.598162,"eighty":46.234326,"marketCap":361933053192},{"date":"2025-03-07","current":86.967867,"twenty":21.272159,"median":29.776497,"eighty":47.262672,"marketCap":372048536534},{"date":"2025-03-14","current":87.297994,"twenty":21.312935,"median":29.921453,"eighty":47.521968,"marketCap":373460820421},{"date":"2025-03-21","current":87.467185,"twenty":21.372316,"median":30.010192,"eighty":47.89618,"marketCap":374184615913},{"date":"2025-03-28","current":83.825918,"twenty":21.389415,"median":30.126715,"eighty":48.261552,"marketCap":358607276516},{"date":"2025-04-04","current":83.379331,"twenty":21.435567,"median":30.174737,"eighty":48.747733,"marketCap":356696779975},{"date":"2025-04-11","current":72.032729,"twenty":21.494114,"median":30.270609,"eighty":49.07539,"marketCap":308156016027},{"date":"2025-04-17","current":70.990694,"twenty":21.518555,"median":30.298444,"eighty":49.644664,"marketCap":303698190767},{"date":"2025-04-25","current":74.584061,"twenty":21.543267,"median":30.350267,"eighty":50.064841,"marketCap":319070612002},{"date":"2025-05-02","current":81.529025,"twenty":21.580616,"median":30.452813,"eighty":50.539236,"marketCap":342014260268}],"updateTime":1746315506649}}}